Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LNG-IUS combined with COC for irregular vaginal bleeding and adenomyosis symptoms
ChiCTR2100053110Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of avatrombopag, ethinyl estradiol + drospirenone and baogong zhixue keli in adenomyosis (4 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Irregular vaginal bleeding rate, Visual analogue pain scale and 3 more. Started Nov 2021; status: recruiting.
02
Drugs
avatrombopagethinyl estradiol + drospirenonebaogong zhixue keli
03
Conditions
adenomyosis
Beyond the preview
Go deeper on ChiCTR2100053110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053110.